An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC

PHASE2CompletedINTERVENTIONAL
Enrollment

812

Participants

Timeline

Start Date

April 29, 2015

Primary Completion Date

March 7, 2018

Study Completion Date

August 27, 2021

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Nivolumab

Trial Locations (90)

0

Local Institution - 0056, Dublin

Local Institution - 0349, Tullamore, Offaly

1121

Local Institution - 0053, Budapest

1125

Local Institution - 0347, Budapest

1140

Local Institution - 0005, Vienna

2730

Local Institution - 0020, Herlev

4032

Local Institution - 0178, Debrecen

4600

Local Institution - 0002, Wels

5000

Local Institution - 0173, Odense

5020

Local Institution - 0003, Salzburg

7624

Local Institution - 0054, Pécs

8028

Local Institution - 0111, Barcelona

8035

Local Institution - 0110, Barcelona

9000

Local Institution - 0021, Aalborg

11527

Local Institution - 0051, Athens

14564

Local Institution - 0177, Nea Kifisia Athens

15006

Local Institution - 0104, A Coruña

17176

Local Institution - 0346, Stockholm

18014

Local Institution - 0103, Granada

22185

Local Institution - 0342, Lund

26504

Local Institution - 0148, Pátrai

28034

Local Institution - 0114, Madrid

28040

Local Institution - 0117, Madrid

28041

Local Institution - 0116, Madrid

28046

Local Institution - 0105, Madrid

29010

Local Institution - 0106, Málaga

33006

Local Institution - 0337, Oviedo

38320

Local Institution - 0107, San Cristóbal de La Laguna

39008

Local Institution - 0109, Santander

41013

Local Institution - 0118, Seville

41345

Local Institution - 0193, Gothenburg

46010

Local Institution - 0161, Valencia

46026

Local Institution - 0102, Valencia

50009

Local Institution - 0163, Zaragoza

57010

Local Institution - 0147, Thessaloniki

71110

Local Institution - 0052, Heraklion

90230

Local Institution - 0022, Oulu

115478

Local Institution - 0160, Moscow

197758

Local Institution - 0100, Saint Petersburg

198255

Local Institution - 0099, Saint Petersburg

300167

Local Institution - 0187, Timișoara

400015

Local Institution - 0097, Cluj-Napoca

400058

Local Institution - 0098, Cluj-Napoca

410469

Local Institution - 0192, Oradea

FI-28500

Local Institution - 0023, Pori

ST4 6QG

Local Institution - 0058, Galway

60-693

Local Institution - 0087, Poznan

44-100

Local Institution - 0158, Gliwice

41-803

Local Institution - 0184, Zabrze

80-214

Local Institution - 0086, Gdansk

90-302

Local Institution - 0088, Lodz

04-141

Local Institution - 0089, Warsaw

3000-602

Local Institution - 0094, Coimbra

1099-023

Local Institution - 0093, Lisbon

1769-001

Local Institution - 0090, Lisbon

4099-001

Local Institution - 0092, Porto

4200-072

Local Institution - 0091, Porto

4200-319

Local Institution - 0159, Porto

022328

Local Institution - 0095, Bucharest

030171

Local Institution - 0096, Bucharest

03010

Local Institution - 0119, Alicante

08036

Local Institution - 0162, Barcelona

08916

Local Institution - 0112, Barcelona

09006

Local Institution - 0108, Burgos

07198

Local Institution - 0113, Palma de Mallorca

581 85

Local Institution - 0348, Linköping

171 76

Local Institution - 0120, Stockholm

SE-70185

Local Institution - 0339, Örebro

AB25 2ZN

Local Institution - 0345, Aberdeen

N18 1QX

Local Institution - 0127, London

M20 4BX

Local Institution - 0191, Manchester

SO16 6YD

Local Institution - 0131, Southampton

ME16 9QQ

Local Institution - 0128, Maidstone

G12 0YN

Local Institution - 0195, Glasgow

PR2 9HT

Local Institution - 0132, Preston

LE1 5WW

Local Institution - 0167, Leicester

SM2 5PT

Local Institution - 0196, Sutton

Local Institution - 0189, Sutton

CH63 4JY

Local Institution - 0171, Bebington

LL18 5UJ

Local Institution - 0340, Bodelwyddan, Rhyl

BD9 6RJ

Local Institution - 0344, Bradford

BS2 8ED

Local Institution - 0190, Bristol

CF14 2TL

Local Institution - 0133, Cardiff

HU16 5JQ

Local Institution - 0126, Cottingham

W1T 7HA

Local Institution - 0165, London

W6 8RF

Local Institution - 0169, London

HA6 2RN

Local Institution - 0194, Northwood

PL6 8DH

Local Institution - 0166, Plymouth

S10 5SJ

Local Institution - 0124, Sheffield

CV2 2DX

Local Institution - 0338, West Midlands

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

PPD Development, LP

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY